Literature DB >> 7868925

Recruitment of alloreactive natural killer cells to the rat peritoneum by a transfected cell line secreting rat recombinant interleukin-2.

G Løvik1, J T Vaage, C Naper, H B Benestad, B Rolstad.   

Abstract

In order to obtain large numbers of natural killer (NK) cells from single rats for functional studies, we have devised a method for the generation of IL-2-activated NK cells in vivo. Rats were implanted intraperitoneally with cell-impermeable diffusion chambers (DC) containing cultures of transfected Chinese hamster ovary (CHO) cells secreting rat recombinant interleukin-2 (rIL-2). This resulted in a dramatic increase in the peritoneal exudate cell (PEC) number with a peak (300-1000 x 10(6)) 1 week after implantation. The majority were mononuclear cells of which a large proportion were CD3-NKR-P1+ NK cells, but with substantial numbers of macrophages (M phi) and CD3+8+NKR-P1+ T cells also. The NK activity against standard tumor target cells was high among PEC from six different inbred rat strains tested. However, the NK cell-mediated reactivity against concanavalin A (ConA)-activated T cell blasts from a panel of major histocompatibility complex (MHC) congenic strains differed widely. PEC from some strains (PVG, LOU/C, and AO) efficiently lysed all the MHC-disparate lymphoblasts. In other strains (BN and LEW) more restricted allorecognition repertoires were observed, whereas PEC from one strain (DA) were unresponsive. The secretion of rat rIL-2 intraperitoneally did not lead to a significant increase in the IL-2 level in the blood or in the total number or activity of NK cells in blood and spleen. The present method represents a most potent technique for generating large numbers of functional rat NK cells and shows the high efficiency with which IL-2 can induce NK cell recruitment in vivo.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7868925     DOI: 10.1016/0022-1759(94)00270-7

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  7 in total

Review 1.  Peritoneal damage: the inflammatory response and clinical implications of the neuro-immuno-humoral axis.

Authors:  Tarik Sammour; Arman Kahokehr; Mattias Soop; Andrew G Hill
Journal:  World J Surg       Date:  2010-04       Impact factor: 3.352

2.  Strain-dependent expression of four structurally related rat Ly49 receptors; correlation with NK gene complex haplotype and NK alloreactivity.

Authors:  Lise Kveberg; Ke-Zheng Dai; Erik Dissen; James C Ryan; Bent Rolstad; John T Vaage; Christian Naper
Journal:  Immunogenetics       Date:  2006-10-07       Impact factor: 2.846

3.  Identification of the rat NKG2D ligands, RAE1L and RRLT, and their role in allograft rejection.

Authors:  Ming Zhuo; Masato Fujiki; Mouer Wang; Karine Piard-Ruster; Lu-En Wai; Liang Wei; Olivia M Martinez; Sheri M Krams
Journal:  Eur J Immunol       Date:  2010-06       Impact factor: 5.532

4.  An autosomal dominant locus, Nka, mapping to the Ly-49 region of a rat natural killer (NK) gene complex, controls NK cell lysis of allogeneic lymphocytes.

Authors:  E Dissen; J C Ryan; W E Seaman; S Fossum
Journal:  J Exp Med       Date:  1996-05-01       Impact factor: 14.307

5.  Recruitment and activation of natural killer (NK) cells in vivo determined by the target cell phenotype. An adaptive component of NK cell-mediated responses.

Authors:  R Glas; L Franksson; C Une; M L Eloranta; C Ohlén; A Orn; K Kärre
Journal:  J Exp Med       Date:  2000-01-03       Impact factor: 14.307

6.  Immune reconstitution and graft-versus-host reactions in rat models of allogeneic hematopoietic cell transplantation.

Authors:  Severin Zinöcker; Ralf Dressel; Xiao-Nong Wang; Anne M Dickinson; Bent Rolstad
Journal:  Front Immunol       Date:  2012-11-30       Impact factor: 7.561

7.  T cell deficiency in spinal cord injury: altered locomotor recovery and whole-genome transcriptional analysis.

Authors:  David Satzer; Catherine Miller; Jacob Maxon; Joseph Voth; Christina DiBartolomeo; Rebecca Mahoney; James R Dutton; Walter C Low; Ann M Parr
Journal:  BMC Neurosci       Date:  2015-11-06       Impact factor: 3.288

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.